BACKGROUND: Individuals with advanced HIV infection naïve to antiretroviral therapy represent a special population of patients frequently encountered in clinical practice. They are at high risk of disease progression and death, and their viroimmunologic response following the initiation of highly active antiretroviral therapy may be more incomplete or slower than that of other patients. Infection management in such patients can also be complicated by underlying conditions, comorbidities, and the need for concomitant medications. AIM: To provide practical guidelines to those clinicians providing care to HIV-infected patients in terms of diagnostic assessment, monitoring, and treatment. CONCLUSIONS: The principals of antiretroviral treatment in asymptomatic naïve patients with advanced HIV infection are the same as those applicable to the general population with asymptomatic HIV infection. Naïve patients with advanced HIV infection and a history of AIDS-defining illnesses urgently need antiretroviral treatment, with the choice of antiretroviral regimen and timetable based on such factors as concomitant treatment and prophylaxis, drug interactions, and potential concomitant drug toxicity. Finally, an adequate counseling program - both before and after HIV-testing - that includes aspects other than treatment adherence monitoring is a crucial step in disease management.
BACKGROUND: Individuals with advanced HIV infection naïve to antiretroviral therapy represent a special population of patients frequently encountered in clinical practice. They are at high risk of disease progression and death, and their viroimmunologic response following the initiation of highly active antiretroviral therapy may be more incomplete or slower than that of other patients. Infection management in such patients can also be complicated by underlying conditions, comorbidities, and the need for concomitant medications. AIM: To provide practical guidelines to those clinicians providing care to HIV-infectedpatients in terms of diagnostic assessment, monitoring, and treatment. CONCLUSIONS: The principals of antiretroviral treatment in asymptomatic naïve patients with advanced HIV infection are the same as those applicable to the general population with asymptomatic HIV infection. Naïve patients with advanced HIV infection and a history of AIDS-defining illnesses urgently need antiretroviral treatment, with the choice of antiretroviral regimen and timetable based on such factors as concomitant treatment and prophylaxis, drug interactions, and potential concomitant drug toxicity. Finally, an adequate counseling program - both before and after HIV-testing - that includes aspects other than treatment adherence monitoring is a crucial step in disease management.
Authors: Juan Berenguer; Juan González; Federico Pulido; Belén Padilla; José Luis Casado; Rafael Rubio; José Rarmón Arribas Journal: Clin Infect Dis Date: 2001-12-19 Impact factor: 9.079
Authors: A Antinori; A Cingolani; L Alba; A Ammassari; D Serraino; B C Ciancio; F Palmieri; A De Luca; L M Larocca; L Ruco; G Ippolito; R Cauda Journal: AIDS Date: 2001-08-17 Impact factor: 4.177
Authors: Mathew Simcock; Monika Blasko; Urs Karrer; Barbara Bertisch; Miklos Pless; Liisa Blumer; Samir Vora; James Owen Robinson; Enos Bernasconi; Benedetta Terziroli; Sophie Moirandat-Rytz; Hansjakob Furrer; Bernard Hirschel; Pietro Vernazza; Pedram Sendi; Martin Rickenbach; Heiner C Bucher; Manuel Battegay; Michael T Koller Journal: Antivir Ther Date: 2007
Authors: P Nunn; R Brindle; L Carpenter; J Odhiambo; K Wasunna; R Newnham; W Githui; S Gathua; M Omwega; K McAdam Journal: Am Rev Respir Dis Date: 1992-10
Authors: S Leone; G Gregis; G Quinzan; D Velenti; G Cologni; L Soavi; V Ravasio; D Ripamonti; F Suter; F Maggiolo Journal: Infection Date: 2011-01-19 Impact factor: 3.553
Authors: Patrick Ryscavage; Sean Kelly; Jonathan Z Li; P Richard Harrigan; Babafemi Taiwo Journal: Antimicrob Agents Chemother Date: 2014-04-14 Impact factor: 5.191